This website isn’t supported by Internet Explorer.
We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
ARISE is a prospective, multi-centre, open-label,non-interventional,
single-arm study of Ryzodeg® in patients with T2D aiming to assess
glycaemic control and other clinical parameters in real-world settings
across six countries.
UPDATES is a prospective non-interventional study investigating the
treatment effect of Tresiba® in adult patients with type 2 diabetes in
Saudi Arabia.